Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer. Systemic dosing of these powerful immune stimulants has historically been limited by broad immune activation and toxicity. We have developed methods to localize cytokines specifically and persistently within tumors thereby creating intense hot spots of inflammation that activate a comprehensive anti-tum...
Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer. Systemic dosing of these powerful immune stimulants has historically been limited by broad immune activation and toxicity. We have developed methods to localize cytokines specifically and persistently within tumors thereby creating intense hot spots of inflammation that activate a comprehensive anti-tumor immune response. Our mission is to translate this approach into the clinic and demonstrate superior efficacy compared to available options.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.